Chris T. Williamson - Concepedia

Author

Chris T. Williamson

Also Known As

C T Williamson, C. Williamson, Chris T. Williamson, Chris Williamson, Chris T. Williamson, Colton J. Williamson, Williamson, Chris

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Breast Cancer Now Institute of Cancer Research University of Calgary Cancer Research UK University College London

About

Chris T. Williamson is an author at Breast Cancer Now specializing in tumor biology, medicine, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	68
2	Immunology	1	1	68
3	Pathology	1	1	68
4	Tumor Biology	1	1	68
5	Virology	1	1	68

Chris T. Williamson

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer Joaquı́n Mateo, Suzanne Carreira, Shahneen Sandhu, New England Journal of Medicine	2015	2.1K
ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A Chris T. Williamson, Rowan Miller, Helen N. Pemberton, Nature Communications	2016	375
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors Timothy A. Yap, Brent O’Carrigan, Marina S. Penney, Journal of Clinical Oncology	2020	237
ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors Chris T. Williamson, Huong Muzik, Ali G. Turhan, Molecular Cancer Therapeutics	2010	190
Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53 Chris T. Williamson, Eiji Kubota, Jeffrey D. Hamill, EMBO Molecular Medicine	2012	125
PREX: PeroxiRedoxin classification indEX, a database of subfamily assignments across the diverse peroxiredoxin family Laura Soito, Chris T. Williamson, Stacy T. Knutson, Nucleic Acids Research	2010	111
Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines James Campbell, Colm J. Ryan, Rachel Brough, Cell Reports	2016	108
Modeling Therapy Resistance in <i>BRCA1/2</i> -Mutant Cancers Amy Dréan, Chris T. Williamson, Rachel Brough, Molecular Cancer Therapeutics	2017	86
Synthetic Lethal Targeting of <i>ARID1A</i> -Mutant Ovarian Clear Cell Tumors with Dasatinib Rowan Miller, Rachel Brough, Ilirjana Bajrami, Molecular Cancer Therapeutics	2016	83
The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status M Kim, Chris T. Williamson, Julie Prudhomme, Oncogene Viral ReplicationViral TropismImmunologyPathologyVirology	2010	68

Page 1